Open Access Gold as soon as Publ. Version/Full Text is submitted to ZB.
Activation of the NF-kappa B pathway alters the phenotype of MSCs in the tracheal aspirates of preterm infants with severe BPD.
Am. J. Physiol. Lung Cell Mol. Physiol. 315, L87-L101 (2018)
Mesenchymal stromal cells (MSCs) are released into the airways of preterm infants following lung injury. These cells display a proinflammatory phenotype and are associated with development of severe bronchopulmonary dysplasia (BPD). We aimed to characterize the functional properties of MSCs obtained from tracheal aspirates of 50 preterm infants who required invasive ventilation. Samples were separated by disease severity. The increased proliferative capacity of MSCs was associated with longer duration of mechanical ventilation and higher severity of BPD. Augmented growth depended on nuclear accumulation of NF kappa Bp65 and was accompanied by reduced expression of cytosolic alpha-smooth muscle actin (alpha-SMA). The central role of NF-kappa B signaling was confirmed by inhibition of I kappa B alpha phosphorylation. The combined score of proliferative capacity, accumulation of NF kappa Bp65, and expression of alpha-SMA was used to predict the development of severe BPD with an area under the curve (AUC) of 0.847. We mimicked the clinical situation in vitro, and stimulated MSCs with IL-1 beta and TNF-alpha. Both cytokines induced similar and persistent changes as was observed in MSCs obtained from preterm infants with severe BPD. RNA interference was employed to investigate the mechanistic link between NF kappa Bp65 accumulation and alterations in phenotype. Our data indicate that determining the phenotype of resident pulmonary MSCs represents a promising biomarker-based approach. The persistent alterations in phenotype, observed in MSCs from preterm infants with severe BPD, were induced by the pulmonary inflammatory response. NF kappa Bp65 accumulation was identified as a central regulatory mechanism. Future preclinical and clinical studies, aimed to prevent BPD, should focus on phenotype changes in pulmonary MSCs.
Impact Factor
Scopus SNIP
Web of Science
Times Cited
Times Cited
Scopus
Cited By
Cited By
Altmetric
4.092
0.997
10
17
Annotations
Special Publikation
Hide on homepage
Publication type
Article: Journal article
Document type
Scientific Article
Keywords
Alpha-sma ; Bronchopulmonary Dysplasia ; Mesenchymal Stromal Cells ; Nf-kappa B ; Preterm; Mesenchymal Stem-cells; Chronic Lung-disease; Bronchopulmonary Dysplasia; Stromal Cells; Myofibroblastic Differentiation; Premature-infants; Dendritic Cells; Postnatal Lung; Apoptosis; Alveolar
Language
english
Publication Year
2018
HGF-reported in Year
2018
ISSN (print) / ISBN
1040-0605
e-ISSN
1522-1504
Quellenangaben
Volume: 315,
Issue: 1,
Pages: L87-L101
Publisher
American Physiological Society
Publishing Place
Bethesda, Md. [u.a.]
Reviewing status
Peer reviewed
POF-Topic(s)
30202 - Environmental Health
30504 - Mechanisms of Genetic and Environmental Influences on Health and Disease
30504 - Mechanisms of Genetic and Environmental Influences on Health and Disease
Research field(s)
Lung Research
Immune Response and Infection
Immune Response and Infection
PSP Element(s)
G-552100-001
G-501793-001
G-501793-001
WOS ID
WOS:000440952000009
Scopus ID
85051283205
PubMed ID
29644893
Erfassungsdatum
2018-06-21